Skip to main content
Contact Us
Subscribe
E-Edition
76°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Incannex Healthcare Inc. - Common Stock
(NQ:
IXHL
)
2.500
-0.280 (-10.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Incannex Healthcare Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
6 Largest Psychedelic Compound-Based R & D Stocks In Decline
September 10, 2023
The 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were down 2.6%, on average, this week and are now only up 6.5% YTD.
Via
Talk Markets
6 Largest Psychedelic Compound-Based R & D Stocks Up 4%, On Average, Last Week
September 05, 2023
The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index were UP 3.9%, on average, last week and are now only UP 9.4% YTD.
Via
Talk Markets
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
Via
Benzinga
August Recap: Largest Psychedelic Compound-Based R & D Stocks Down 15%
September 02, 2023
The 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were down 15.0%, on average, in August and are now only up 5.3% YTD.
Via
Talk Markets
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
August 28, 2023
Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials
Via
Benzinga
6 Largest Psychedelic Compound-Based R&D Stocks Continued Downwards, On Average, This Week
August 25, 2023
Only 2 of the 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were up this week.
Via
Talk Markets
Incannex preparing psilocybin therapy FDA IND application
August 24, 2023
--News Direct--
Via
News Direct
Exposures
Product Safety
Incannex To Prepare FDA IND Application For Psilocybin-Assisted Psychedelic Psychotherapy
August 24, 2023
Psychennex Pty Ltd, a subsidiary of Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has commenced preparations of an investigational new drug (‘IND’) application to the U.S.
Via
Benzinga
Exposures
Product Safety
Cannabis Stock Gainers And Losers From August 24, 2023
August 24, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Incannex full steam ahead towards sleep apnoea trial
August 23, 2023
--News Direct--
Via
News Direct
Topics
Cannabis
Exposures
Cannabis
Product Safety
FDA Approves Clinical Trial Of Incannex's Dronabinol-Based Drug For Obstructive Sleep Apnea
August 22, 2023
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from the US Food and Drug Administration to conduct the company’s investigational new drug (&ls
Via
Benzinga
Exposures
Product Safety
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
August 21, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
August 21, 2023
Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds
Via
Benzinga
Topics
Cannabis
Economy
Exposures
Cannabis
Interest Rates
Largest Psychedelic Compound-Based R&D Stocks Continue Downward Trend
August 20, 2023
The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index were down an average of 6% last week and are now down 17.2% MTD. We take a look at them in...
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
August 17, 2023
Via
Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published
Via
Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
August 17, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
So Far, August Isn't Kind To 4 Of 6 Constituents In Our Psychedelic Drug Stocks Index
August 13, 2023
The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index are down an average of 11.9% so far in August but are still up YTD.
Via
Talk Markets
Clarion Clinics Begins Accepting Registrations For Psychedelic Treatment Interest
August 08, 2023
Clarion Clinics Group Pty Ltd, a subsidiary of Incannex Healthcare Ltd (NASDAQ: IXHL) (ASX:IHL) is now accepting direct registration of interest in treatment from potential clients via its website...
Via
Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
August 16, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
August 07, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
August 14, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances...
Via
Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
August 11, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
July Summary: Largest Psychedelic Compound-Based R&D Stocks Up 16%, On Average
July 30, 2023
All but 1 of the 6 largest psychedelic compound-based research & development stocks advanced in July and are ranked below as to their performances so far in July:
Via
Talk Markets
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 4, 2023
August 04, 2023
Via
Benzinga
Cannabis Stock Movers For August 3, 2023
August 03, 2023
Via
Benzinga
Marijuana Stock Movers For August 2, 2023
August 02, 2023
Via
Benzinga
Marijuana Stock Movers For August 1, 2023
August 01, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.